DIEBOLD NIXDORF, Inc: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Oct 28, 2020 and accepted by EDGAR at Oct 28, 2020, 16:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-01 to 2020-09-30 | $995.2m | us-gaap:Revenues |
| Revenue | 9 months2020-01-01 to 2020-09-30 | $2.80bn | us-gaap:Revenues |
| Cost of revenue | 3 months2020-07-01 to 2020-09-30 | $711.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-01-01 to 2020-09-30 | $2.04bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-07-01 to 2020-09-30 | $284.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-01-01 to 2020-09-30 | $758.5m | us-gaap:GrossProfit |
| Research and development | 3 months2020-07-01 to 2020-09-30 | $30.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-01-01 to 2020-09-30 | $93.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-07-01 to 2020-09-30 | $226.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-01-01 to 2020-09-30 | $629.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-07-01 to 2020-09-30 | $23.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-01 to 2020-09-30 | $18.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-07-01 to 2020-09-30 | $144.3m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-01-01 to 2020-09-30 | $240.6m | us-gaap:InterestExpense |
| Income tax | 3 months2020-07-01 to 2020-09-30 | −$21.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-30 | −$4.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-01 to 2020-09-30 | −$101.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | −$217.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-07-01 to 2020-09-30 | −$1.31 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2020-01-01 to 2020-09-30 | −$2.81 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | −$209.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-01-01 to 2020-09-30 | $12.2m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months2020-01-01 to 2020-09-30 | $6.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2020-09-30 | $1.84bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-09-30 | $3.63bn | us-gaap:Assets |
| Current liabilities | At period end2020-09-30 | $1.45bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2020-09-30 | −$806.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000028823-20-000151. Last ingested by Listed: Oct 28, 2026, 07:18 ET. Listed shows no prices and gives no investment advice.